Lifelong medication is usually required after endovascular stenting, and the medication regimen is determined by the doctor’s instructions for one year after the procedure and one year after that. A combination of two different types of antiplatelet aggregation drugs, such as aspirin enteric-coated tablets in combination with clopidogrel tablets, is usually required for one year after endovascular stenting. If the patient has undergone endovascular stenting, it is recommended that regular outpatient visits be made to the clinic to determine the specific dosage and frequency of medications based on the patient’s underlying condition and a thorough assessment of the patient’s blood counts, coagulation function, liver and kidney function, and other conditions. One year after endovascular stenting, one type of antiplatelet aggregation drugs can be taken, such as aspirin enteric-coated tablets, clopidogrel tablets, indobufen tablets or bivalirudin tablets, etc. Patients with endovascular stenting are recommended to visit the clinic regularly, and choose the specific type of drugs and decide the specific dosage and frequency after the follow-up examination by professional physicians. It is recommended that patients with endovascular stenting should have regular outpatient visits to adjust their medication regimen according to the doctor’s instructions.